Lats-IN-1 protects cardiac function and promotes regeneration after myocardial infarction by targeting the hippo pathway
Frontiers in Pharmacology · 03.10.2024 · 15
DOI: 10.3389/fphar.2024.1463465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.10.2024. Verfasst von Hua Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Myocardial infarction (MI), a leading cause of heart failure, is characterized by the loss of cardiomyocytes, which severely limits the heart’s regenerative capacity. The Hippo pathway, which regulates cell proliferation and apoptosis, presents a therapeutic target for cardiac regeneration. This study explores the efficacy of Lats-IN-1, a LATS1/2 kinase inhibitor targeting the Hippo pathway, as a novel treatment for MI.
Methods
Using male C57BL/6 mice subjected to surgically induced MI, we administered Lats-IN-1 and evaluated the effects on cardiac function, infarct size, cardiomyocyte proliferation, and apoptosis through various assays and echocardiographic assessments.
Results
Our results demonstrate that Lats-IN-1 significantly improves cardiac function, as evidenced by enhanced ejection fraction and reduced ventricular dimensions. Additionally, Lats-IN-1 decreased infarct size and apoptosis rates while promoting cardiomyocyte proliferation. These findings suggest that Lats-IN-1 promotes cardiac repair and regeneration.
Discussion
By modulating the Hippo pathway and reducing apoptosis markers, Lats-IN-1 represents a promising therapeutic strategy for improving outcomes in heart diseases characterized by cardiomyocyte loss. This study highlights the critical role of the Hippo pathway in facilitating cardiac regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
- Department of Adult Cardiac Surgery, The Sixth Medical Center of PLA General Hospital, Beijing, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Emergency Intensive Care Unit(EICU), The Affiliated Hospital of Yangzhou University, Yangzhou University, Guangling District, Yangzhou City, Jiangsu Province, China.
Zitieren
APA
Shen, H., Wang, Q., Liu, B., Wang, Y., Zhou, D., Zhang, L., & Zhuang, J. (2024). Lats-IN-1 protects cardiac function and promotes regeneration after myocardial infarction by targeting the hippo pathway. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1463465
Vancouver
Shen H, Wang Q, Liu B, Wang Y, Zhou D, Zhang L, et al. Lats-IN-1 protects cardiac function and promotes regeneration after myocardial infarction by targeting the hippo pathway. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1463465
BibTeX
@article{Shen2024,
author = {Shen, Hua and Wang, Qing and Liu, Bohan and Wang, Yihui and Zhou, Dandan and Zhang, Lin and Zhuang, Jinqiang},
title = {Lats-IN-1 protects cardiac function and promotes regeneration after myocardial infarction by targeting the hippo pathway},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1463465}
}
EUVIMED